SJOGREN'S SYNDROME (SS)
Clinical trials for SJOGREN'S SYNDROME (SS) explained in plain language.
Never miss a new study
Get alerted when new SJOGREN'S SYNDROME (SS) trials appear
Sign up with your email to follow new studies for SJOGREN'S SYNDROME (SS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cell therapy trial aims to tame severe autoimmune diseases in children
Disease control Not yet recruitingThis early-stage study tests a new cell therapy called YTS109 in 12 children aged 5 to 17 with severe autoimmune diseases like lupus and scleroderma that haven't responded to standard treatments. The therapy is given as a single IV infusion, and the main goals are to check its sa…
Matched conditions: SJOGREN'S SYNDROME (SS)
Phase: PHASE1 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated May 26, 2026 06:57 UTC
-
Could engineered immune cells tame autoimmune diseases?
Disease control Not yet recruitingThis early-phase study tests a new treatment called BEN301 for people with autoimmune diseases like scleroderma, rheumatoid arthritis, Sjogren's syndrome, and inflammatory muscle diseases. BEN301 uses specially engineered immune cells (CAR-Tregs) to calm the overactive immune sys…
Matched conditions: SJOGREN'S SYNDROME (SS)
Phase: EARLY_PHASE1 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated May 26, 2026 06:53 UTC